China may make ‘vaccine diplomacy’ gains by giving doses to nations in short supply, but trial data on one of the vaccines has shown the need for credibility. Illustration: Henry Wong China may make ‘vaccine diplomacy’ gains by giving doses to nations in short supply, but trial data on one of the vaccines has shown the need for credibility. Illustration: Henry Wong
China may make ‘vaccine diplomacy’ gains by giving doses to nations in short supply, but trial data on one of the vaccines has shown the need for credibility. Illustration: Henry Wong

China’s Covid-19 vaccines in demand, but will efficacy data affect its diplomacy goals?

  • Beijing could make ‘vaccine diplomacy’ gains by providing doses to developing countries in short supply
  • But the release of efficacy data in Brazil for the vaccine of Chinese firm Sinovac served as a reminder that such efforts rely on medical credibility

Topic |   Coronavirus pandemic
China may make ‘vaccine diplomacy’ gains by giving doses to nations in short supply, but trial data on one of the vaccines has shown the need for credibility. Illustration: Henry Wong China may make ‘vaccine diplomacy’ gains by giving doses to nations in short supply, but trial data on one of the vaccines has shown the need for credibility. Illustration: Henry Wong
China may make ‘vaccine diplomacy’ gains by giving doses to nations in short supply, but trial data on one of the vaccines has shown the need for credibility. Illustration: Henry Wong
READ FULL ARTICLE